206
Participants
Start Date
November 30, 2010
Primary Completion Date
January 31, 2013
Study Completion Date
January 31, 2013
INSULIN GLARGINE
Pharmaceutical form: solution for injection Route of administration: sub-cutaneous Dose regimen: once a day at bedtime
INSULIN GLULISINE
Pharmaceutical form: solution for injection Route of administration: sub-cutaneous Dose regimen: three times a day, preferably just before the meal
Investigational Site Number 78803, Tunis
Investigational Site Number 12464, Durban
Investigational Site Number 12465, Durban
Investigational Site Number 710001, Durban
Investigational Site Number 710002, Durban
Investigational Site Number 12484, Port Elizabeth
Investigational Site Number 710003, Port Elizabeth
Investigational Site Number 12466, Bloemfontein
Investigational Site Number 710006, Bloemfontein
Investigational Site Number 1, Riyadh
Investigational Site Number 48401, Guadalajara
Investigational Site Number 48402, Guadalajara
Investigational Site Number 48404, Guadalajara
Investigational Site Number 48403, Monterrey
Investigational Site Number 01201, Algeries
Investigational Site Number 01202, Algiers
Investigational Site Number 01203, Algiers
Investigational Site Number 01204, Algiers
Investigational Site Number 03201, Caba
Investigational Site Number 03202, Caba
Investigational Site Number 03203, Caba
Investigational Site Number 03204, Caba
Investigational Site Number 03205, Morón
Investigational Site Number 17003, Barranquilla
Investigational Site Number 17004, Bogotá
Investigational Site Number 17005, Bogotá
Investigational Site Number 17007, Bogotá
Investigational Site Number 17006, Medellín
Investigational Site Number 01, Kuwait City
Investigational Site Number 12468, Benoni
Investigational Site Number 710004, Benoni
Investigational Site Number 12467, Pretoria
Investigational Site Number 710005, Pretoria
Investigational Site Number 78801, Sfax
Investigational Site Number 78805, Sfax
Investigational Site Number 78802, Tunis
Investigational Site Number 78804, Tunis
Investigational Site Number 076-007, Curitiba
Investigational Site Number 076-003, Distrito Federal
Investigational Site Number 076-010, Fortaleza
Investigational Site Number 076-006, Marília
Investigational Site Number 076-004, Porto Alegre
Investigational Site Number 076-002, São Paulo
Lead Sponsor
Sanofi
INDUSTRY